Second Sight Medical (EYES) Prices 7.5M Share Common Offering at $1/Sh

Second Sight Medical Products Inc. (NASDAQ: EYES) today announced the pricing of an underwritten public offering of 7,500,000 shares of common stock, no par value (the “Common Stock”) at an offering price of $1.00 per share of Common Stock for aggregate gross proceeds of $7,500,000, prior to deducting underwriting discounts, commissions and other offering expenses. The offering is expected to close on May 5, 2020, subject to the satisfaction of customary closing conditions.

Second Sight Medical Products intends to use the net proceeds from the offering for accrued expenses, working capital and general corporate purposes, which may include, without limitation, engaging in partnerships, business combinations, or acquisitions or investing in businesses that may or may not be related to its current operations.

ThinkEquity, a division of Fordham Financial Management, Inc., is acting as representative of the underwriters in the offering.

You May Also Be Interested In

• Datavault AI secures $25M convertible note from Streeterville Capital
• Evolution Petroleum launches stock offering to fund Permian Basin deal
• Singularity Future Technology prices $1.8M direct offering at $3 a share